COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin
about
Fatty acid metabolites in rapidly proliferating breast cancerAspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?Breast cancer survival among young women: a review of the role of modifiable lifestyle factorsResults of observational studies: analysis of findings from the Nurses' Health StudyHiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality.Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patients.Impact of acetylsalicylic Acid on the clinicopathological characteristics and prognosis of patients with invasive breast cancer.Loss of PPARγ expression in mammary secretory epithelial cells creates a pro-breast tumorigenic environment.Effects of cyclooxygenase-2 gene silencing on the biological behavior of SKOV3 ovarian cancer cellsPrognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort studyTargeting the COX-2 Pathway to Improve Therapeutic Response in the Obese Breast Cancer Patient PopulationUse of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidencePalbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.Beta blockers and angiotensin-converting enzyme inhibitors' purported benefit on breast cancer survival may be explained by aspirin usePhysiological COX-2 expression in breast epithelium associates with COX-2 levels in ductal carcinoma in situ and invasive breast cancer in young womenClinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis.New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis.Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling.Role of Aspirin in Breast Cancer Survival.Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness.The tumor promoting roles of HSP60 and HIF2α in gastric cancer cells.Hypoxia promotes 786-O cells invasiveness and resistance to sorafenib via HIF-2α/COX-2.Low expression of microRNA-143 is related to degenerative scoliosis possibly by regulation of cyclooxygenase-2 expression.Autoimmune diseases and breast cancer recurrence: a Danish nationwide cohort study.Statins, aspirin and risk of venous thromboembolic events in breast cancer patients.Prognostic genes of breast cancer revealed by gene co-expression network analysis.COX-2 expression in ovarian cancer: an updated meta-analysis.The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size.The Presence of Cyclooxygenase 2, Tumor-Associated Macrophages, and Collagen Alignment as Prognostic Markers for Invasive Breast Carcinoma Patients.Proteomic profiling of cancer stem cells derived from primary tumors of HER2/Neu transgenic mice.Therapeutic positioning of secretory acetylated APE1/Ref-1 requirement for suppression of tumor growth in triple-negative breast cancer in vivo.Origin, Methods, and Evolution of the Three Nurses' Health Studies
P2860
Q21090755-5C45E7C2-4105-43E7-9B70-30501E9C44F1Q26749127-1FF73A31-77D5-4E20-98B9-019732DDA60EQ26766205-7A9E6C99-982D-4997-93B7-FA4A774EAE39Q27006022-1D8D1840-B615-4FD2-B8AB-6D0984CB9EFEQ33739341-7F393461-40B1-426B-817C-F6A16271FE94Q34316720-36EA7046-A3FB-4D89-B992-25C585AE0F47Q34403601-33CC898B-6740-4B5F-9BF5-EE59B95B8E66Q34522002-667E736B-C269-4EC7-9C83-DC4D9CB3200FQ34540858-AFC4148A-B277-4A99-9539-A54879686347Q34996098-38114C04-5CE7-4067-BE19-496E01AA6FF5Q35911030-4FC6F84D-E9FA-4946-ABB0-AF69ED2E932BQ36114823-28F53A51-004F-4839-A33A-51E9A3C07D93Q36267669-4EEC91C9-E06C-4F19-8471-CC4D66910280Q36561589-6619C1CA-47C0-4665-BE62-F62D2EA8D0E8Q36932703-FB412897-23CB-45F5-A991-0C16F78379EFQ37672896-C5AE538B-6111-4714-B487-448417FC068EQ37701526-56933186-8B6F-4B62-A91B-628CC7970CACQ38550876-EE229A2F-32C4-49F4-ACFF-F129A3006A30Q38726739-8662C031-7D77-482B-A003-D7D3213E4AF1Q38735032-0B8878C9-AF04-494D-BEE2-2122F4DFD365Q38751543-4AFDF65B-AEB1-43C5-AAD2-84D66D5BB3E3Q38916161-58A4BF31-3B92-4A93-ACEE-CBE3681E498AQ38930844-91004DAF-2FB2-465C-8DD4-C3C58F07AA20Q41046953-7F0BF2F8-708D-4A06-92A8-E6CD01498A07Q41630053-D46AF277-73CD-481B-B9A6-EB45F3B02D68Q43770339-5E00A86E-27CE-4394-9989-763391FFAF8AQ47095948-37D6B237-78B8-49F3-8A9E-194123FB46A9Q47152650-DBAD956D-5E4F-4B4E-80F0-62AA9D5D74A6Q47273449-F2CC8A4B-B969-4C99-8098-80B914015E05Q50076692-DDBD518B-BF5D-43D6-9F8F-7EB7DC800EB7Q54291180-F873DA52-D51C-4311-81F8-8DA4363A2C5BQ55259742-3EA1F55A-00EC-4B02-AD96-99C1F41B354EQ56550215-A3D9B924-0EA2-405A-B909-D2B7B876D623
P2860
COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
COX-2 expression predicts wors ...... y the association with aspirin
@ast
COX-2 expression predicts wors ...... y the association with aspirin
@en
type
label
COX-2 expression predicts wors ...... y the association with aspirin
@ast
COX-2 expression predicts wors ...... y the association with aspirin
@en
prefLabel
COX-2 expression predicts wors ...... y the association with aspirin
@ast
COX-2 expression predicts wors ...... y the association with aspirin
@en
P2093
P2860
P1476
COX-2 expression predicts wors ...... y the association with aspirin
@en
P2093
Laura Collins
Michelle D Holmes
Rulla M Tamimi
Stuart J Schnitt
Wendy Y Chen
P2860
P2888
P304
P356
10.1007/S10549-011-1651-7
P407
P577
2011-07-05T00:00:00Z